CP-012
Phase 1- Indications
- Parkinson's disease
Company intelligence / Profile preview
BDD Pharma is a UK-based contract research organization and CDMO specializing in the rapid development of innovative oral drug products. Leveraging proprietary technologies like OralogiK™ for complex release profiles and integrated Lean Clinical Development™, they accelerate timelines from formulation through Phase I/II clinical trials. Their expertise includes biopharmaceutics, gamma scintigraphy imaging for in vivo performance visualization, and end-to-end support from concept to first-in-human data. They serve both large pharma clients and small biotech innovators globally.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BDD Pharma.